1887

Chapter 10 : Viral Disease of the Eye

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Viral Disease of the Eye, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch10-1.gif /docserver/preview/fulltext/10.1128/9781555819439/9781555819422.ch10-2.gif

Abstract:

The eye is a fascinating organ not only because of its complex anatomy but also because it is a partly immunologically privileged site, which protects itself from potentially destructive systemic immune responses. This characteristic, however, may hinder defense against infectious agents, including numerous viruses, which may manifest with a variety of ocular diseases (Table 1). The first part of this chapter discusses ocular anatomy and physiology, as well as the principle clinical syndromes, which are usually classified according to the affected anatomic structures. The latter part discusses the major viral ocular pathogens and highlights selected risk groups, such as infants and patients infected with human immunodeficiency virus (HIV).

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Anatomy of the eye. Courtesy of the National Eye Institute, National Institutes of Health, USA.

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

HIV retinopathy with cotton wool spots. Courtesy Retinal Gallery and S Cohen (http://retinagallery.com/displayimage.php?pid=3301).

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Herpes simplex virus keratitis with dendritic ulcer, visible after fluorescein staining.

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Herpes simplex virus keratitis with geographical ulcer. Courtesy of Hee K. Yang, Young K. Han, Won R. Wee, Jin H. Lee, and Ji W. Kwon; Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (http://www.jmedicalcasereports.com/content/5/1/328/figure/F1).

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Cytomegalovirus retinitis with retinal haemorrhages and exudates. Courtesy Retinal Gallery and Don Gass (http://retinagallery.com/displayimage.php?pid=3989).

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Herpes zoster ophthalmicus. Courtesy of William Charles Caccamise and Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa. Note the dermatomal distribution of the lesion and scar of Hutchinson's sign at the tip of the nose which may precede the development of herpes zoster ophthalmicus.

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

Courtesy of William Charles Caccamise and Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa.

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 8
FIGURE 8

Eyelid molluscum contagiosum with typical umbillicated lesion. Courtesy Jesse Vislise and Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa.

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819439.ch10
1. Willoughby CE, Ponzin D, Ferrari S, Lobo A, Landau K, Omidi Y. 2010. Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function—a review. Clin Experiment Ophthalmol 38:211.
2. Mcaa CS. 1982. The eye and visual nervous system: anatomy, physiology and toxicology. Environ Health Perspect 44:18.
3. Newman H, Gooding C. 2013. Viral ocular manifestations: a broad overview. Rev Med Virol 23:281294.[PubMed]
4. Tiffany JM. 2008. The normal tear film. Dev Ophthalmol 41:120.[PubMed]
5. Taylor AW. 2009. Ocular immune privilege. Eye (Lond) 23:18851889.[PubMed]
6. Jha P, Bora PS, Bora NS,. 2011. Role of complement in ocular immune response, p 3343. In Dartt DA, Dana R, D'Amore P, Niederkorn J (ed), Immunology, Inflammation and Diseases of the Eye. Elsevier Ltd, San Diego.
7. Shuttleworth G, Easty D,. 2009. Viral disease of the eye, p 143166. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, 3rd ed. ASM Press, Washington, DC.
8. Visscher KL, Hutnik CM, Thomas M. 2009. Evidence-based treatment of acute infective conjunctivitis: breaking the cycle of antibiotic prescribing. Can Fam Physician 55:10711075.[PubMed]
9. Morrow GL, Abbott RL. 1998. Conjunctivitis. Am Fam Physician 57:735746.[PubMed]
10. Foster SC. 2007. Ganciclovir gel—a new topical treatment for herpetic keratitis. US Ophthalmic Rev 3:5256.
11. Jabs DA, Mudun A, Dunn JP, Marsh MJ. 2000. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 130:469476.[PubMed]
12. Smith JR, Mackensen F, Rosenbaum JT. 2007. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 3:219226.[PubMed]
13. Watson PG, Hayreh SS. 1976. Scleritis and episcleritis. Br J Ophthalmol 60:163191.[PubMed]
14. Lowder CY, Char DH. 1984. Uveitis. A review. West J Med 140:421432.[PubMed]
15. Ahuja Y, Couch SM, Razonable RR, Bakri SJ. 2008. Infectious retinitis: a review. Retinal Physician DOI: www.retinalphysician.com/articleviewer.aspx?articleID=102293[PubMed]
16. Holland GN. 1994. The progressive outer retinal necrosis syndrome. Int Ophthalmol 18:163165.[PubMed]
17. Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan CC, Brown DM, Thorne JE, Wang R, Cunningham ET Jr. 2014. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review. Ocul Immunol Inflamm 22:175182.
18. Chen HP, Kuo HK, Tsai SH, Chen YJ, Kao ML. 2004. Acute retinal necrosis syndrome: clinical manifestations and visual outcomes. Chang Gung Med J 27:193200.[PubMed]
19. UNAIDS 2013. UNAIDS report on the global AIDS epidemic 2013, Geneva. Available from http://www.unaids.org [accessed 08.03.14].[PubMed]
20. Lima B. 2004. Ophthalmic manifestations of HIV infection. Digit J Ophthalmol 10. Available from http://www.djo.harvard.edu/site.php?url=/physicians/oa/674.[PubMed]
21. Belfort R Jr. 2000. The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture. Am J Ophthalmol 129:18.[PubMed]
22. Cunningham ET Jr, Margolis TP. 1998. Ocular manifestations of HIV infection. N Engl J Med 339:236244.[PubMed]
23. Lewis JM, Nagae Y, Tano Y. 1996. Progressive outer retinal necrosis after bone marrow transplantation. Am J Ophthalmol 122:892895.[PubMed]
24. Govender P, Hansrajb R, Naaidooc K, Visser L. 2010. Ocular manifestations of HIV / AIDS: a literature review (part 1). S Afr Optom 70:8188.
25. Pillay D, Geretti AM, Weiss R,. 2009. Human immunodeficiency viruses, p 897938. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
26. Kaleem MA, Ramsahai S, Del Fierro K, Rasul S, Onumah C, Lerebours V, Gajjala J, Copeland RA, Jones LS. 2012. Ocular findings in human immunodeficiency virus patients in Washington, DC. Int Ophthalmol 32:145151.[PubMed]
27. Moraes HV Jr. 2002. Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol 13:397403.[PubMed]
29. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. 2008. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis 8:111.[PubMed]
30. Simmons A. 2002. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis 186(Suppl 1):S71S77.[PubMed]
31. Aurelian L,. 2008. Herpes simplex virus: general features, p 383397. In Mahy B, van Regenmortel M (ed), Encyclopedia of Virology, 3rd ed. Elsevier Academic Press, Philadelphia.
32. Ritterband DC, Friedberg DN. 1998. Virus infections of the eye. Rev Med Virol 8:187201.[PubMed]
33. Krachmer J, Mannis M, Holland E. 2005. Fundamentals, diagnosis and management, In Cornea 1:629–636, 1065–1071, 1086–1089, 1095–1098. Elsevier Inc., Edinburgh.
34. Forsgren M, Klapper P,. 2009. Herpes simplex virus type 1 and type 2, p 95131. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
35. Farooq A, Shah A, Shukla D. 2010. The role of herpesviruses in ocular infections. Virus Adaptation Treat 2:115123.
36. Shimeld C, Easty DL,, Tullo AB, Blyth WA,, Hill TJ,. 1985a. Spread of herpes simplex virus to the eye following cutaneous inoculation in the skin of the snout of the mouse, p 3947. In Maudgal PC, Missotten L (ed), Herpetic Eye Diseases. Dr W Junk, Dordrecht, The Netherlands.
37. Tullo AB, Easty DL, Hill TJ, Blyth WA. 1982. Ocular herpes simplex and the establishment of latent infection. Trans Ophthalmol Soc U K 102:1518.[PubMed]
38. Dawson CR, Togni B. 1976. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 21:121135.[PubMed]
39. Easty DL, Shimeld C, Claoue CM, Menage M. 1987. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res 6:6974.[PubMed]
40. Preiser W, Doerr HW, Buxbaum S, Rabenau HF, Baatz H. 2004. Acute retinal necrosis six years after herpes simplex encephalitis: an elusive immune deficit suggested by insufficient test sensitivity. J Med Virol 73:250255.[PubMed]
41. Dhaliwal DK, Romanowski EG, Yates KA, Hu D, Goldstein M, Gordon YJ. 2001. Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus. Am J Ophthalmol 131:506507.[PubMed]
42. Liesegang TJ. 1999. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18:127143.[PubMed]
43. Kaye SB, Baker K, Bonshek R, Maseruka H, Grinfeld E, Tullo A, Easty DL, Hart CA. 2000. Human herpesviruses in the cornea. Br J Ophthalmol 84:563571.[PubMed]
44. Zheng X. 2002. Reactivation and donor-host transmission of herpes simplex virus after corneal transplantation. Cornea 21(7 Suppl):S90S93.[PubMed]
45. Dong X, Shi W, Xie L. 2001. [Penetrating keratoplasty in active herpes simplex stromal keratitis]. [Article in Chinese]. Zhonghua Yan Ke Za Zhi 37:118120.[PubMed]
46. De Groot-Mijnes JD, Rothova A, Van Loon AM, Schuller M, Ten Dam-Van Loon NH, De Boer JH, Schuurman R, Weersink AJ. 2006. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol 141:313318.[PubMed]
47. Wilhelmus KR. 2007. Therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev (1):CD002898.[PubMed]
48. Wilhelmus KR. 2000. The treatment of herpes simplex virus epithelial keratitis. Trans Am Ophthalmol Soc 98:505532.[PubMed]
49. Wellings PC, Awdry PN, Bors FH, Jones BR, Brown DC, Kaufman HE. 1972. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol 73:932942.[PubMed]
50. Wilhelmus KR, Beck RW, Moke PS, Dawson CR, Barron BA, Jones DB, Kaufman HE, Kurinij N, Stulting RD, Sugar J, Cohen EJ, Hyndiuk RA, Asbell PA Herpetic Eye Disease Study Group. 1998. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 339:300306.[PubMed]
51. Herpetic Eye Disease Study Group. 2000. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 118:10301036.[PubMed]
52. Pepose JS, Newman C, Bach MC, Quinn TC, Ambinder RF, Holland GN, Hodstrom PS, Frey HM, Foos RY. 1987. Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology 94:414424.[PubMed]
53. Chatis PA, Crumpacker CS. 1992. Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother 36:15891595.[PubMed]
54. Kanski J, Bowling B. 2011. Clinical Ophthalmology: A Systematic Approach. Elsevier, Edinburgh.
55. Easty DL,. 1985. The management of herpes simplex keratitis, p 179227. In Easty DL (ed), Virus Disease of the Eye. Lloyd-Luke (Medical Books) Ltd, London, United Kingdom.
56. Cheong I, Flegg PJ, Brettle RP, Welsby PD, Burns SM, Dhillon B, Leen CL, Gray JA. 1992. Cytomegalovirus disease in AIDS: the Edinburgh experience. Int J STD AIDS 3:324328.[PubMed]
57. Culbertson WW, Blumenkranz MS, Pepose JS, Stewart JA, Curtin VT. 1986. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology 93:559569.[PubMed]
58. Rodrigues MM, Palestine A, Nussenblatt R, Masur H, Macher AM. 1983. Unilateral cytomegalovirus retinochoroiditis and bilateral cytoid bodies in a bisexual man with the acquired immunodeficiency syndrome. Ophthalmology 90:15771582.[PubMed]
59. Jabs DA, Martin BK, Forman MS, Ricks MO Cytomegalovirus Retinitis and Viral Resistance Research Group. 2005. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. J Infect Dis 192:640649.[PubMed]
60. Baldassano V, Dunn JP, Feinberg J, Jabs DA. 1995. Cytomegalovirus retinitis and low CD4+ T-lymphocyte counts. N Engl J Med 333:670.[PubMed]
61. Griffiths P,. 2009. Cytomegalovirus, p 161197. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
62. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. 2003. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 121:466476.[PubMed]
63. Lehoang P, Girard B, Robinet M, Marcel P, Zazoun L, Matheron S, Rozenbaum W, Katlama C, Morer I, Lernestedt JO, Saraux H, Pouliquen Y, Gentilini M, Rousselie F. 1989. Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 96:865873, discussion 873–874.[PubMed]
64. Severin M, Hartmann C. 1988. Endothelial alterations in AIDS with cytomegalovirus infection. Ophthalmologica 196:710.[PubMed]
65. Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. 2008. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834840.[PubMed]
66. Silverstein BE, Conrad D, Margolis TP, Wong IG. 1997. Cytomegalovirus-associated acute retinal necrosis syndrome. Am J Ophthalmol 123:257258.[PubMed]
67. Doft BH, Gass DM. 1985. Punctate outer retinal toxoplasmosis. Arch Ophthalmol 103:13321336.[PubMed]
68. Jabs DA, Enger C, Dunn JP, Forman M, Hubbard L CMV Retinitis and Viral Resistance Study Group. 1998. Cytomegalovirus retinitis and viral resistance: 3. Culture results. Am J Ophthalmol 126:543549.[PubMed]
69. Knox CM, Chandler D, Short GA, Margolis TP. 1998. Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis. Use in diagnostic dilemmas. Ophthalmology 105:3744, discussion 44–45.[PubMed]
70. Cvetković RS, Wellington K,. 2005. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs 65:859878. In Hayat MA (ed) Pediatric Cancer, Volume 4: Diagnosis, Therapy, and Prognosis, Springer Science & Business Media, New York.[PubMed]
71. Goldberg DE, Smithen LM, Angelilli A, Freeman WR. 2005. HIV-associated retinopathy in the HAART era. Retina 25:633649, quiz 682–683.[PubMed]
72. Holland GN. 2000. New issues in the management of patients with AIDS-related cytomegalovirus retinitis. Arch Ophthalmol 118:704706.[PubMed]
73. Jabs DA, Bolton SG, Dunn JP, Palestine AG. 1998. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 126:817822.[PubMed]
74. Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR. 2000. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology 107:877881, discussion 881–883.[PubMed]
75. Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT Jr, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA. 1999. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA 282:16331637.[PubMed]
76. Whitcup SM. 2000. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA 283:653657.[PubMed]
77. Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A. 2011. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation 92:217223.
78. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL, Jaffe HS. 1997. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med 126:257263.[PubMed]
79. Akula SK, Ma PE, Peyman GA, Rahimy MH, Hyslop NE Jr, Janney A, Ashton P. 1994. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS. Br J Ophthalmol 78:677680.[PubMed]
80. Henry K,, Cantrill H, Fletcher C, Chinnock BJ, Balfour HH. 1987. Use of intravitreal ganciclovir (dihydroxyproproxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 103:1723.[PubMed]
81. Young S, Morlet N, Besen G, Wiley CA, Jones P, Gold J, Li Y, Freeman WR, Coroneo MT. 1998. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology 105:14041410.[PubMed]
82. Zaal MJ, Völker-Dieben HJ, D'Amaro J. 2000. Risk and prognostic factors of postherpetic neuralgia and focal sensory denervation: a prospective evaluation in acute herpes zoster ophthalmicus. Clin J Pain 16:345351.[PubMed]
83. Gungor IU, Ariturk N, Beden U, Darka O. 2006. Necrotizing scleritis due to varicella zoster infection: a case report. Ocul Immunol Inflamm 14:317319.[PubMed]
84. Livir-Rallatos C, El-Shabrawi Y, Zatirakis P, Pellett PE, Stamey FR, Foster CS. 1998. Recurrent nodular scleritis associated with varicella zoster virus. Am J Ophthalmol 126:594597.[PubMed]
85. Pepose JS. 1997. The potential impact of the varicella vaccine and new antivirals on ocular disease related to varicella-zoster virus. Am J Ophthalmol 123:243251.[PubMed]
86. Breuer J,. 2009. Varicella Zoster, p 133160. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
87. Svozílková P, Ríhová E, Diblík P, Kuthan P, Kovarík Z, Kalvodová B. 2005. Varicella zoster virus acute retinal necrosis following eye contusion: case report. Virol J 2:77.[PubMed]
88. Burke DG, Kalayjian RC, Vann VR, Madreperla SA, Shick HE, Leonard DG. 1997. Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. J Infect Dis 176:10801084.[PubMed]
89. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. 2008. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5:47.[PubMed]
90. Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T. 2000. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 107:15071511.[PubMed]
91. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T, Boon R, Saltzman R Collaborative Famciclovir Herpes Zoster Study Group. 1995. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:8996.[PubMed]
92. Liesegang TJ. 2004. Herpes zoster virus infection. Curr Opin Ophthalmol 15:531536.[PubMed]
93. Haque T, Crawford D,. 2009. Epstein-Barr virus, p 199221. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
94. Slobod KS, Sandlund JT, Spiegel PH, Haik B, Hurwitz JL, Conley ME, Bowman LC, Benaim E, Jenkins JJ, Stocks RM, Gan Y, Sixbey JW. 2000. Molecular evidence of ocular Epstein-Barr virus infection. Clin Infect Dis 31:184188.[PubMed]
95. Lemaitre C, Bodaghi B, Murat F, Fardeau C, Cassoux N, Rosenberg F, LeHoang P. 2004. EBV-associated uveitis diagnosed by polymerase chain reaction (PCR): report of 3 cases. Invest Ophthalmol Vis Sci 45:E-Abstract 1670.
96. Ongkosuwito JV, Van der Lelij A, Bruinenberg M, Wienesen-van Doorn M, Feron EJ, Hoyng CB, de Keizer RJ, Klok AM, Kijlstra A. 1998. Increased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. Br J Ophthalmol 82:245251.
97. Méchaï F, Boutolleau D, Manceron V, Gasnault J, Quertainmont Y, Brosseau JP, Delfraissy JF, Labetoulle M, Goujard C. 2007. Human herpesvirus 6-associated retrobulbar optic neuritits in an HIV infected patient: response to anti-herpesvirus therapy and long term outcome. J Med Virol 79:931934.
98. Chan CC. 2003. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 101:275292.[PubMed]
99. Viswalingam ND. 1993. Adenovirus keratoconjunctivitis: and enigma. Eye Suppl 7 (Suppl 3):57.
100. Tullo AB, Higgins PG. 1980. An outbreak of adenovirus type 4 conjunctivitis. Br J Ophthalmol 64:489493.[PubMed]
101. Benkő M,. 2008. Adenoviruses: pathogenesis, p 2429. In Mahy B, van Regenmortel M (ed), Encyclopedia of Virology, 3rd ed. Elsevier Academic Press, Philadelphia.
102. Leppard K,. 2008. Adenoviruses: molecular biology, p 1723. In Mahy B, van Regenmortel M (ed), Encyclopedia of Virology, 3rd ed. Elsevier Academic Press, Philadelphia.
103. Abelson M, Shapiro A. 2010. The many faces of adenovirus. Review of Ophthalmology 17:6669.
104. Bialasiewicz A. 2007. Adenoviral keratoconjunctivitis. Sultan Qaboos Univ Med J 7:1523.[PubMed]
105. Cooper RJ, Yeo AC, Bailey AS, Tullo AB. 1999. Adenovirus polymerase chain reaction assay for rapid diagnosis of conjunctivitis. Invest Ophthalmol Vis Sci 40:9095.[PubMed]
106. Dalapathy S, Lily TK, Roy S, Madhavan HN. 1998. Development and use of nested polymerase chain reaction (PCR) for the detection of adenovirus from conjunctivitis specimens. J Clin Virol 11:7784.[PubMed]
107. Mielke J, Grüb M, Freudenthaler N, Deuter CM, Beck R, Zierhut M. 2005. [Epidemic keratoconjunctivitis. Detecting adenoviruses]. [Article in German]. Ophthalmologe 102:968970.[PubMed]
108. Maitreyi RS, Dar L, Muthukumar A, Vajpayee M, Xess I, Vajpayee RB, Seth P, Broor S. 1999. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerg Infect Dis 5:267269.[PubMed]
109. Lashkevich VA, Koroleva GA, Lukashev AN, Denisova EV, Katargina LA. 2004. Enterovirus uveitis. Rev Med Virol 14:241254.[PubMed]
110. Kaye SB, Morton CE, Tong CY, O'Donnell NP. 1998. Echovirus keratoconjunctivitis. Am J Ophthalmol 125:187190.[PubMed]
111. de Groot-Mijnes JD, de Visser L, Zuurveen S, Martinus RA, Völker R, ten Dam-van Loon NH, de Boer JH, Postma G, de Groot RJ, van Loon AM, Rothova A. 2010. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol 150:628636.
112. Vajpayee RB, Sharma N, Chand M, Tabin GC, Vajpayee M, Anand JR. 1998. Corneal superinfection in acute hemorrhagic conjunctivitis. Cornea 17:614617.[PubMed]
113. Minor P, Muir P,. 2009. Enteroviruses, p 601624. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
114. Perry RT, Halsey NA. 2004. The clinical significance of measles: a review. J Infect Dis 189(Suppl 1):S4S16.[PubMed]
115. Asaria P, MacMahon E. 2006. Measles in the United Kingdom: can we eradicate it by 2010? BMJ 333:890895.[PubMed]
116. Titiyal JS, Pal N, Murthy GV, Gupta SK, Tandon R, Vajpayee RB, Gilbert CE. 2003. Causes and temporal trends of blindness and severe visual impairment in children in schools for the blind in North India. Br J Ophthalmol 87:941945.[PubMed]
117. Leahey AB, Shane JJ, Listhaus A, Trachtman M. 1997. Molluscum contagiosum eyelid lesions as the initial manifestation of acquired immunodeficiency syndrome. Am J Ophthalmol 124:240241.[PubMed]
118. Schornack MM, Siemsen DW, Bradley EA, Salomao DR, Lee HB. 2006. Ocular manifestations of molluscum contagiosum. Clin Exp Optom 89:390393.[PubMed]
119. Charteris DG, Bonshek RE, Tullo AB. 1995. Ophthalmic molluscum contagiosum: clinical and immunopathological features. Br J Ophthalmol 79:476481.[PubMed]
120. Meadows KP, Tyring SK, Pavia AT, Rallis TM. 1997. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol 133:987990.[PubMed]
121. Fillmore GL, Ward TP, Bower KS, Dudenhoefer EJ, Grabenstein JD, Berry GK, Madigan WP Jr. 2004. Ocular complications in the Department of Defense Smallpox Vaccination Program. Ophthalmology 111:20862093.[PubMed]
122. Hopkins RJ, Lane JM. 2004. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Clin Infect Dis 39:819826.[PubMed]
123. Smee DF, Bailey KW, Wong MH, Wandersee MK, Sidwell RW. 2004. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. J Infect Dis 190:11321139.[PubMed]
124. Kern ER, Hartline C, Harden E, Keith K, Rodriguez N, Beadle JR, Hostetler KY. 2002. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. Antimicrob Agents Chemother 46:991995.
125. Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, Barone L, Burns C, Rhodes G, Tohan S, Huggins JW, Baker RO, Buller RL, Touchette E, Waller K, Schriewer J, Neyts J, DeClercq E, Jones K, Hruby D, Jordan R. 2005. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopox challenge. J Virol 79:1313913149.
126. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM Jr. 1997. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399411.[PubMed]
127. Kesson AM, Ferguson JK, Rawlinson WD, Cunningham AL. 1997. Progressive vaccinia treated with ribavirin and vaccinia immune globulin. Clin Infect Dis 25:911914.[PubMed]
128. Karcioglu ZA, Issa TM. 1997. Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye. Br J Ophthalmol 81:595598.[PubMed]
129. Gray RH, Johnson GJ, Freedman A. 1992. Climatic droplet keratopathy. Surv Ophthalmol 36:241253.[PubMed]
130. McDonnell JM, McDonnell PJ, Sun YY. 1992. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci 33:184189.[PubMed]
131. Yun NE, Walker DH. 2012. Pathogenesis of Lassa fever. Viruses 4:20312048.[PubMed]
132. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF. 2012. Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2:276286.[PubMed]
133. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD. 2004. Avian influenza virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 101:13561361.
134. Belser JA, Sleeman K, Pearce MB, Katz JM, Gubareva LV, Tumpey TM. 2012. Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route. Antimicrob Agents Chemother 56:16161618.
135. Gupta RK, Best J, MacMahon E. 2005. Mumps and the UK epidemic 2005. BMJ 330:11321135.[PubMed]
136. North DP. 1953. Ocular complications of mumps. Br J Ophthalmol 37:99101[PubMed]
137. Onal S, Toker E. 2005. A rare ocular complication of mumps: kerato-uveitis. Ocul Immunol Inflamm 13:395397.[PubMed]
138. Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti AB. 2010. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23:577589.
139. Buggage RR. 2003. Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Curr Opin Ophthalmol 14:420425.[PubMed]
140. Reploeg MD, Storch GA, Clifford DB. 2001. Bk virus: a clinical review. Clin Infect Dis 33:191202.[PubMed]
141. Hedquist BG, Bratt G, Hammarin AL, Grandien M, Nennesmo I, Sundelin B, Seregard S. 1999. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthalmology 106:129132.
142. Jacobi C, Wenkel H, Jacobi A, Korn K, Cursiefen C, Kruse FE. 2007. Hepatitis C and ocular surface disease. Am J Ophthalmol 144:705711.[PubMed]
143. Tsoumani A, Theopistos V, Katsanos K, Asproudis I, Tsianos EV. 2013. Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C. Eur Rev Med Pharmacol Sci 17:11231131.
144. Jarhling P,. 1997. Viral haemorrhagic fevers, p 591602. In Zajtchuk R (ed), Textbook of Military Medicine. Office of the Surgeon General Department of the Army United States of America.
145. Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, Kumar G, Smith JR, Kainulainen MH, Whitmer S, Ströher U, Uyeki TM, Ribner BS, Yeh S. 2015. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372:24232427.[PubMed]
146. Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, Saadi R, Ahmed N. 2005. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 112:313318.[PubMed]
147. Lim WK, Mathur R, Koh A, Yeoh R, Chee SP. 2004. Ocular manifestations of dengue fever. Ophthalmology 111:20572064.[PubMed]
148. Mahendradas P, Ranganna SK, Shetty R, Balu R, Narayana KM, Babu RB, Shetty BK. 2008. Ocular manifestations associated with chikungunya. Ophthalmology 115:287291.[PubMed]
149. Boppana SB, Ross SA, Fowler KB. 2013. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 57(Suppl 4):S178S181.[PubMed]
150. Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS. 2013. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis 56:12321239.[PubMed]
151. Anderson KS, Amos CS, Boppana S, Pass R. 1996. Ocular abnormalities in congenital cytomegalovirus infection. J Am Optom Assoc 67:273278.
152. Malik AN, Hildebrand GD, Sekhri R, Russell-Eggitt IM. 2008. Bilateral macular scars following intrauterine herpes simplex type 2 infection. J AAPOS 12:305306.
153. McAlister Gregg N. 2001. Congenital cataract following German measles in the mother. 1942. [classical article]. Rev Med Virol 11:277283, discussion 84–85.[PubMed]
154. de Visser L, Braakenburg A, Rothova A, de Boer JH. 2008. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol 146:292297.[PubMed]
155. Suzuki J, Goto H, Komase K, Abo H, Fujii K, Otsuki N, Okamoto K. 2010. Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. Graefes Arch Clin Exp Ophthalmol 248:14871491.[PubMed]
156. Wensing B, Relvas LM, Caspers LE, Valentincic NV, Stunf S, de Groot-Mijnes JD, Rothova A. 2011. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology 118:19051910.[PubMed]
157. Best J, Icenogle J, Brown D,. 2009. Rubella, p 561592. In Zuckerman A, Banatvala J, Schoub B, Griffiths P, Mortimer P (ed), Principles and Practice of Clinical Virology, 6th ed. John Wiley and Sons Ltd, Chichester.
158. Givens KT, Lee DA, Jones T, Ilstrup DM. 1993. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol 77:358363.[PubMed]
159. Hertzberg R. 1968. Twenty-five-year follow-up of ocular defects in congenital rubella. Am J Ophthalmol 66:269271.[PubMed]

Tables

Generic image for table
TABLE 1

Common viruses affecting the eye

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Generic image for table
TABLE 2

Viral causes of ocular clinical syndromes

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Generic image for table
TABLE 3

Ocular HIV manifestations

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Generic image for table
TABLE 4

Ocular manifestations of herpesviruses

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Generic image for table
TABLE 5

Laboratory diagnosis of common ocular viral infections

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Generic image for table
TABLE 6

Adenoviral ocular syndromes

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10
Generic image for table
TABLE 7

Common congenital viral infections with ocular manifestations

Citation: Newman H. 2017. Viral Disease of the Eye, p 151-167. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Fourth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819439.ch10

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error